Drugs / SAFEstart
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00331201 | Jul 2005 → Apr 2006 | diarrheal disease | Intermountain Health Care, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAFEstart | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00331201 ↗ |
| Known as | Simulated Amniotic Fluid for Enteral administration | “We termed the product SAFEstart, using the acronym Simulated Amniotic Fluid for Enteral administration.” NCT00331201 ↗ |
| Route | Other | “20 mL/kg/day of SAFEstart will be administered (every three hour gavage or nipple feedings)” NCT00331201 ↗ |